Biopure Announces Fourth Quarter 2003 Conference Call and Webcast.Business Editors CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dec. 4, 2003 Biopure Corporation (Nasdaq:BPUR BPUR Biopure Corporation (stock symbol) ) will announce its financial results for the fourth fiscal quarter and year ended October 31, 2003, on Thursday, December 11, 2003, after the market closes. Following the announcement, Biopure President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. Thomas A. Moore will host a conference call at 4:30 p.m. Eastern Standard Time (EST EST electroshock therapy. EST abbr. electroshock therapy ). The dial-in numbers for investors are 1-877-270-4107 (US/Canada) and 1-706-634-1920 (International). A live audio webcast of the conference call will be available from the investor section of Biopure's web site at www.biopure.com and will be archived for 30 days. The webcast can also be heard by individual investors at www.companyboardroom.com and by institutional investors who subscribe to Verb 1. subscribe to - receive or obtain regularly; "We take the Times every day" subscribe, take buy, purchase - obtain by purchase; acquire by means of a financial transaction; "The family purchased a new car"; "The conglomerate acquired a new company"; StreetEvents at www.streetevents.com. An audio replay of the conference call will be available from approximately 7:30 p.m. EST, December 11, 2003, until midnight December 19, 2003. To access the replay, dial 1-800-642-1687 (US/Canada) or 1-706-645-9291 (International/Local) and reference conference ID number 4340084. Biopure Corporation Biopure Corporation, headquartered in Cambridge, Mass., is a leading developer, manufacturer and marketer of oxygen therapeutics, a new class of pharmaceuticals that are intravenously administered to deliver oxygen to the body's tissues. Hemopure(R) (hemoglobin glutamer - 250 (bovine)) is approved in South Africa for the treatment of adult surgical patients who are acutely anemic and for the purpose of eliminating, delaying or reducing the need for allogenic allogenic /al·lo·gen·ic/ (-jen´ik) allogeneic. allogenic, adj from individuals of the same species. Tissue transplanted from one person to another is said to be allogenic. red blood cell red blood cell: see blood. transfusion in these patients. Biopure's veterinary product Oxyglobin(R) (hemoglobin glutamer - 200 (bovine)), the only oxygen therapeutic approved by the U.S. Food Drug and Administration and the European Commission, is indicated for the treatment of anemia in dogs. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion